Brad Bugdanowitz is a partner in the firm's business law department and serves as head of the firm’s west coast Life Sciences Practice. He focuses his practice on merger and acquisition transactions, securities offerings and corporate governance. From 2012 to 2017 Mr. Bugdanowitz served as Chairman of the San Francisco office, a period during which the office tripled in size and grew into new practice areas. He joined Goodwin in 2008.

Mr. Bugdanowitz works with investment funds and public and private corporations in structuring and executing minority and control investments, acquisitions, dispositions and public and private offerings of equity and debt securities.






Mr. Bugdanowitz’s experience includes representing:

  • Teva Pharmaceuticals Industries, Ltd. in its acquisition of Auspex Pharmaceuticals, Inc
  • Onyx Pharmaceuticals in its sale to Amgen
  • Roxro Pharma in its sale to Luitpold Pharmaceuticals.
  • Codenomicon Oy in its sale to Synopsys International Limited
  • Royalty Pharma in its acquisition of royalties resulting from commercialization of the drug ibrutinib from Quest Diagnostics, and related collaboration with Aisling Capital and Clarus Ventures
  • ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
  • Anthera Pharmaceuticals, Inc. in its collaboration with Zenyaku Kogyo Co Ltd., preferred stock and convertible note financings, initial and follow-on public common stock offerings, SEC reporting and governance matters
  • Trigemina Holdings, Inc. in its reinversion transaction from Chile to the United States and related financing transactions
  • Sprout Health Group in its growth equity investment by Housatonic Partners
  • NIKE in its $2 billion aggregate bond offerings, strategic partnership with Dyecoo Textile Systems, B.V., SEC reporting and governance matters
  • Passport Capital in its investment in NEOS GeoSolutions
  • JMI Equity in its investments in SiriusDecisions, BigMachines and Paradigm, Ltd.
  • Altos Therapeutics, Aspire Medical, BioClin Therapeutics, Trigemina Holdings, Radiant Medical, Resonance Medical, Wireless Glue Networks in Preferred equity financing transactions
  • Management group in its management led leveraged buyout of Entek Holdings LLC and subsequent representation of ENTEK in its recapitalization, financing and partnership transactions
  • Outward Bound USA, Inc., Pacific Crest Outward Bound School and the Northwest Outward Bound School in various matters on a pro bono basis.

In The News


Dans les Nouvelles




Lettres de Créance



J.D., 1996
The University of Chicago Law School
(with honors)
B.A., 1993
University of California, Santa Cruz
(with honors)



Get In Touch
Entrer en contact
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos clients comptent sur nous pour des services de conseil de classe mondiale, des conseils sur le travail transactionnel complexe et des litiges à enjeux élevés. Spécialisés dans les domaines de la finance, des sciences de la vie, du capital-investissement, de l'immobilier et de la technologie, nous utilisons une approche collaborative et interdisciplinaire pour résoudre les problèmes les plus complexes de nos clients. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique